Needham analyst Rajvindra Gill reiterates MagnaChip Semiconductor (NYSE:MX) with a Buy and maintains $13 price target.
BioNTech And Ryvu Therapeutics Enter Into Global Collaboration To Develop And Commercialize Immuno-Modulatory Small Molecule Candidates
The companies enter a multi-target research collaboration to develop multiple small molecule programs targeting immune modulation in cancer and potentially other disease areas based on targets selected by